At the technical level, we worked on defining the main needs to optimize, adapt and validate our whole system, and each one of its components and derived products to reach a TRL9. At the commercial level, we searched and identified many potential users and analyzed the advantages we can offer to them. We were also able to study different markets, compare our innovation with main competitors and describe BioCopy stakeholders, to evaluate the options we have to establish in the biopharma and animal vaccines markets as a highly competitive alternative. Financially, we could estimate the budget needed to reach commercialization and make projections on sells and profits after market launch.